PAR PHARMACEUTICAL COMPANIES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-15: Reporting owner KNIGHT PETER S; Form 4; Security Common Stock, Option to buy; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-12-15: Reporting owner NORDMANN RONALD M; Form 4; Security Common Stock, Option to buy; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-05-10: Reporting owner HAUGHEY THOMAS; Form 4; Security Common Stock, Option to Buy; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-05-09: Reporting owner HAUGHEY THOMAS; Form 4; Security Common Stock, Option to Buy; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-15 | KNIGHT PETER S Director | 4 | Common Stock, Option to buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $29.90 exercise price | 2011-12-19 | |
| 2011-12-15 | NORDMANN RONALD M Director | 4 | Common Stock, Option to buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $29.90 exercise price | 2011-12-19 | |
| 2011-05-10 | HAUGHEY THOMAS Officer (EVP, CAO, General Counsel) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,800 53,599 owned after | $13.06 exercise price | 2011-05-11 | |
| 2011-05-09 | HAUGHEY THOMAS Officer (EVP, CAO, General Counsel) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −68,591 34,290 owned after | $10.99 exercise price | 2011-05-11 | |
| 2011-05-09 | LEPORE PATRICK G Director, Officer (Chairman, President & CEO) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,467 65,467 owned after | $13.06 exercise price | 2011-05-11 | |
| 2011-03-07 | Campanelli Paul Officer (EVP, Pres-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,525 3,175 owned after | $24.27 exercise price | 2011-03-09 | |
| 2011-03-07 | Campanelli Paul Officer (EVP, Pres-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −68,591 34,290 owned after | $10.99 exercise price | 2011-03-09 | |
| 2011-03-07 | Campanelli Paul Officer (EVP, Pres-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,864 17,593 owned after | $27.71 exercise price | 2011-03-09 | |
| 2011-03-07 | Campanelli Paul Officer (EVP, Pres-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $28.79 exercise price | 2011-03-09 | |
| 2011-03-07 | Campanelli Paul Officer (EVP, Pres-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,885 49,771 owned after | $13.06 exercise price | 2011-03-09 | |
| 2011-01-06 | Tropiano Michael A Officer (EVP and CFO) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,376 16,376 owned after | $36.54 exercise price | 2011-01-10 | |
| 2011-01-06 | Campanelli Paul Officer (EVP, Pres-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,740 17,740 owned after | $36.54 exercise price | 2011-01-10 | |
| 2011-01-06 | HAUGHEY THOMAS Officer (EVP, CAO, General Counsel) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,740 17,740 owned after | $36.54 exercise price | 2011-01-10 |